Eton Pharma to Present at Citizens JMP Life Sciences Conference - May 01, 2024
DEER PARK, Ill., May 01, 2024-- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a pharmaceutical company specializing in treatments for rare diseases, announced that its Chief Executive Officer, Sean Brynjelsen, and Chief Financial Officer, James Gruber, will be presenting at the Citizens JMP Life Sciences Conference in New York. The presentation is scheduled for Monday, May 13, 2024, at 10:00am ET.
Eton Pharmaceuticals is dedicated to developing and commercializing treatments for rare diseases. Currently, the company has five commercial products catering to rare diseases. These products include ALKINDI SPRINKLE®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. Additionally, Eton Pharmaceuticals is working on three more products which are in the late stages of development. These pipeline products are ET-400, ET-600, and ZENEO® hydrocortisone autoinjector.
By focusing on niche markets and rare diseases, Eton Pharmaceuticals aims to address unmet medical needs, providing patients and healthcare providers with innovative treatment options. The company’s approach emphasizes the importance of targeted therapies that can make a significant difference in the lives of those suffering from rare conditions.
Eton Pharmaceuticals continues to make strides in the realm of rare disease treatments, with its existing portfolio and promising pipeline products. The upcoming presentation by its key executives at the Citizens JMP Life Sciences Conference will offer insights into the company's current progress and future plans, underlining its commitment to advancing healthcare solutions for rare diseases.
How to obtain the latest research advancements in the field of biopharmaceuticals?
In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!
